LexisNexis® Mealey's™ Antidepressant Drugs Legal NewsHeadline Antidepressant Drugs Legal News from LexisNexis®Celexa- September 17, 2008 Drug: Celexa Case caption: Jennifer Hillison and Michael Hillison v. Forest Laboratories Inc., et al., No. 08-4190-WAK Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-12 Mealeys... Celexa- September 17, 2008 Drug: Celexa Case caption: Terri Mosher and Christopher Mosher v. Forest Laboratories Inc., et al., No. 08-4181-CV-C-NKL Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-12 Mealeys... Celexa- September 17, 2008 Drug: Celexa Case caption: Suzanne Riccio and David Riccio v. Forest Laboratories Inc., et al., No. 08-4194-CV-C-SOW Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%204-12 Mealeys... Ohio Paxil Birth Defect Claim Began When Cause Known; Plaintiff Must Amend Complaint- (Found September 17, 2008 ) DAYTON, Ohio - A mother's generic Paxil birth defect claim became known when she learned of the possible cause, not when the newborn died, an Ohio federal judge ruled July 22 in dismissing common-law claims and allowing them to be refiled under a state product liability law in effect at the time of discovery (Jennifer M. Deacon, et al. v. Apotex, Corp., et al., No. 07-322, S.D. Ohio, Western Div., Dayton). Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... Lilly Discloses Experts In Cymbalta Suicide Case- (Found September 17, 2008 ) SIOUX FALLS, S.D. - The manufacturer of Cymbalta on Aug. 18 disclosed the names of four experts who will provide testimony supporting its assertion that the antidepressant cannot cause people to commit suicide and that the drug did not cause a 16-year-old boy's suicide in December 2004 (Paul and Cynthia Schilf, et al. v. Eli Lilly & Co., No. 07-CV-04015-LLP, D. S.D.; See June 2008, Page 18). Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... Appeals Court Affirms Dismissal For Delayed Service- (Found September 17, 2008 ) NEW ORLEANS - A federal judge's decision to grant a company's motion to quash summons and return of service and its motion to dismiss under Federal Rule of Civil Procedure 12(b)(5) were affirmed by a federal appeals court on July 24 after it found that the seven-month delay between the plaintiffs' filing of the complaint and its attempt to serve the defendant was not justified (Spencer Gartin, et al. v. Par Pharmaceutical Companies Inc., No. 07-40451, 5th Cir.; 2008 U.S. App. LEXIS 15915)....http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... Fraudulent Concealment Tolls Statute Of Limitations, Parents Say- (Found September 17, 2008 ) DENVER - The parents of an 11-year-old boy who committed suicide while taking Paxil are arguing to the 10th Circuit U.S. Court of Appeals that GlaxoSmithKline plc's alleged fraudulent concealment of adolescent suicide risks tolled the statute of limitations for their claim (Pamela Blain, et al. v. SmithKline Beecham Corporation, et al., No. 08-3131, 10th Cir.; See April 2008, Page 10). Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... Prozac Maker Allowed To File Post-Hearing Brief On Learned Intermediary- (Found September 17, 2008 ) ALBUQUERQUE, N.M. - Eli Lilly & Co. can file a post-hearing brief to address issues concerning the applicability of the learned intermediary doctrine in New Mexico because it could help the court be certain of its finding as to whether the state's high court would adopt the defense, a federal judge ruled Aug. 18 (Mark Gilbert Rimbert v. Eli Lilly & Co., No. CIV 06-874, D. N.M.). Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... Drug Preemption Plaintiff Tells High Court FDA Didn't Consider New Warning- (Found September 17, 2008 ) WASHINGTON, D.C. - The plaintiff in a U.S. Supreme Court drug preemption case says in her Aug. 7 brief that there's no evidence that the U.S. Food and Drug Administration rejected a stronger warning for the anti-nausea drug Phenergan and that Wyeth was not prohibited from adding one to the label (Wyeth v. Diana Levine, No. 06-1249, U.S. Sup.; See June 2008, Page 10). Full story on lexis.comhttp://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... GSK: High Court's Pending Preemption Ruling Has No Bearing On Present Case- (Found September 17, 2008 ) MILWAUKEE - Plaintiffs' request to stay proceedings pending the U.S. Supreme Court's ruling in Levine v. Wyeth (No. 06-1249 U.S. Sup.) should be rejected, the manufacturer of Paxil says in an Aug. 13 brief, because it has not decided whether it will file a motion for summary judgment based on preemption and because the high court's ruling could have not be dispositive on the present case (Linda L. Thompson, et al. v. SmithKline Beecham Corp., dba GlaxoSmithKline, No. 07-C-1124, E.D. Wis.; See...http://www.mealeysonline.com/mealey/ppv/articleSearch.do?searchTerm=%22%205-1 Mealeys... |